Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis
Jurgen Sota(Azienda Ospedaliera Universitaria Senese), Luca Cantarini(University of Siena), Giuseppe Lopalco(University of Bari Aldo Moro), Carlo Salvarani(Sorbonne Université), Paolo Sfriso(University of Padua), Francesco La Torre(Ospedale Vito Fazzi), Manuela Pardeo(Istituti di Ricovero e Cura a Carattere Scientifico), Donato Rigante(Agostino Gemelli University Polyclinic), Claudia Bracaglia(Bambino Gesù Children's Hospital), Rolando Cimaz(University of Milan), Maria Cristina Maggio(University of Palermo), Marco Cattalini(University of Brescia), Antonella Insalaco(Bambino Gesù Children's Hospital), Fabrizio De Benedetti(Bambino Gesù Children's Hospital), Alma Nunzia Olivieri(University of Naples Federico II), Maria Alessio(University of Naples Federico II), Carla Gaggiano(Azienda Ospedaliera Universitaria Senese), Romina Gallizzi(University of Messina), Claudia Fabiani(University of Siena), Salvatore Grosso(University of Siena)
Cited by 616
Related Papers
2018 update of the EULAR recommendations for the management of Behçet's syndrome
|Annals of the Rheumatic Diseases|2018|771
EULAR recommendations for the management of Behçet disease
|Annals of the Rheumatic Diseases|2008|721
Clinical Features, Treatment, and Outcome of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A Multinational, Multicenter Study of 362 Patients
|Arthritis & Rheumatology|2014|430
Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease
|Nature Genetics|2011|355